Amy E. Chervenak
Mayo Clinic · 6 works · 266 citations · h-index 4
Top works
- Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant
- Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
- Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study
- Hydroxycut-related Vanishing Bile Duct Syndrome
- Use of HCV Specific Clinic in the Management of HCV in the DAA Era
- P0851 : Effectiveness of sofosbuvir and ribavirin for genotype 2 and 3 HCV among non-cirrhotic, cirrhotic, and post-transplant patients at 3 US medical centers